Replies to post #176132 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Talon38:

a little backup on "CNS diseases are harder".

https://www.biospace.com/article/down-but-not-out-10-biggest-drug-trials-that-saw-challenges-in-2018/?utm_campaign=GenePool&utm_source=hs_email&utm_medium=email&utm_content=68518799&_hsenc=p2ANqtz-9jVU-roWXjZJYFbXxhdkr0nm_FzfijAgX-joEHpQjZVHuozXe39nayRewOS-D8o1D3odxrpZUGj9QFALvQEep3LFaV5w&_hsmi=68518799

An impressive array of large Pharma/medical research organizations who did not make the cut in 2018. Tiny AVXL CNS disease trials and methods so far present an effective process when considered in this context. Set D3.